Advertisement
U.S. Markets close in 4 hrs 45 mins

Mankind Pharma Limited (MANKIND.NS)

NSE - NSE Real Time Price. Currency in INR
2,565.95-81.05 (-3.06%)
At close: 03:30PM IST
Currency in INR

Valuation Measures4

Market Cap (intraday) 1.06T
Enterprise Value 1.03T
Trailing P/E 54.12
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)9.97
Price/Book (mrq)11.33
Enterprise Value/Revenue 9.64
Enterprise Value/EBITDA 35.46

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 32,835.00
52 Week Low 31,683.05
50-Day Moving Average 32,499.47
200-Day Moving Average 32,256.19

Share Statistics

Avg Vol (3 month) 3651.01k
Avg Vol (10 day) 3260.1k
Shares Outstanding 5400.64M
Implied Shares Outstanding 6N/A
Float 893.98M
% Held by Insiders 176.49%
% Held by Institutions 113.40%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Mar 31, 2024
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 18.43%
Operating Margin (ttm)19.84%

Management Effectiveness

Return on Assets (ttm)N/A
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)106.5B
Revenue Per Share (ttm)265.86
Quarterly Revenue Growth (yoy)12.20%
Gross Profit (ttm)N/A
EBITDA 25.6B
Net Income Avi to Common (ttm)19.63B
Diluted EPS (ttm)48.97
Quarterly Earnings Growth (yoy)10.20%

Balance Sheet

Total Cash (mrq)33.86B
Total Cash Per Share (mrq)84.53
Total Debt (mrq)2.07B
Total Debt/Equity (mrq)2.16
Current Ratio (mrq)N/A
Book Value Per Share (mrq)233.73

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A